* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download (5-Hydroxytryptamine 3).
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Psychedelic therapy wikipedia , lookup
Drug design wikipedia , lookup
Gastrointestinal tract wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Orphan drug wikipedia , lookup
Drug discovery wikipedia , lookup
Toxicodynamics wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacognosy wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Prescription costs wikipedia , lookup
Serotonin syndrome wikipedia , lookup
Drug interaction wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
Neuropharmacology wikipedia , lookup
5-HT3 (5-Hydroxytryptamine 3) Group 3 Drug Classifications/Indications for use (action) Antiemetics – Used to prevent and treat nausea and vomiting. Expected Outcome (Therapeutic Effect) 1. Verbal reports of decreased nausea 2. Decreased frequency or absence of vomiting Subclasses (Names of different classes within this drug classification) 5-HT3 (5-Hydroxytryptamine 3) Prototype: None Ondansetron was first drug of this group. 4 drugs: ondansetron, granisetron, dolestron and palonsetron (all end in TRON). Polonsetron has the longest half-life (40 hours) and is given 30 minutes prior to chemotherapy in the same IV access. Drug action begins rapidly Characteristic Differences h-Hydroxythrptamine3 (5-HT3) drugs are serotonin receptor antagonists. They are used to treat moderate to severe nausea and vomiting associated with cancer chemotherapy, radiation therapy, and postoperative status. These drugs antagonize serotonin receptors, preventing their activation by the effects of emetogenic drugs and toxins. In cancer chemotherapy, emetogenic drugs are thought to stimulate the release of serotonin from the enterochromaffin cells of the small intestine; this released serotonin then activates 5-HT3 receptors located on vagal afferent nerves in the CTZ to initiate the vomiting reflex. o Emetogenic drugs- drugs having the capacity to induce vomiting o Enterochromaffin cells - a type of enteroendocrine cell (specialized endocrine cells of the gastrointestinal tract that produce hormones such as serotonin) occurring in the epithelia lining the lumen of the digestive tract, duodenum of small intestines and the respiratory tract. Rare and slow growing carcinoid tumors develop from these cells. When a tumor arises it has the capacity to secrete large volumes of hormones. o CTZ (chemoreceptor trigger zone) – Signals are relayed to the vomiting center in the medulla oblongata by the activation of the chemoreceptor trigger zone. Receptors involved include serotonin, dopamine, muscarinic. Adverse Effects Adverse effects are mild to moderate. Diarrhea Headache Dizziness Constipation Muscle aches Transient elevation of liver enzymes o Transient - lasting only for a short time; impermanent o What does elevation of liver enzymes mean - Any agent that damages the liver may cause elevation of the liver enzymes Top 3 Concerns w/Patient Care and Nursing Process 1. Administer antiemetic drugs 30 to 60 minutes before radiation therapy or cancer chemotherapy. 2. Some patients may experience less nausea and vomiting if they avoid or decrease food intake for a few hours before scheduled chemotherapy. 3. The 5-HT3 receptor antagonists are usually considered the most effective antiemetics for chemotherapy. Contraindications/Other Children: Use caution when using 5-HT3 drugs. There are varying age/drug suitability issues and some cannot be used in children under the age of 18. Recommended use of 5-HT3 receptor antagonists plus a corticosteroid before administering chemotherapy to pediatric oncology pts. 2 years of age and younger – do not use granisetron and dolasetron 3 years of age and younger – little information available on effects of endansetron 18 years of age and younger – do not use palonosetron Hepatic Impairment: Use cautiously because these drugs are metabolized in the liver. Do not exceed 8 mg dose IV or 8mg daily PO of ordansetron.